Using small molecules to define new targets for the treatment of disease
Riley received his B.S. in Chemistry from the University of Iowa in May of 2015. As an undergraduate, he worked in the lab of Dr. Hien Nguyen synthesizing glycan mimics of the HIV-1 glycoprotein, gp120. Riley joined the Hergenrother lab in the fall of 2015 as a Roger Adams Fellow where he is currently working towards developing a small molecule that evades resistance prevalent in glioblastoma multiforme.
Predictive Compound Accumulation Rules Yield a Broad-Spectrum Antibiotic
Richter, M. F.; Drown, B. S.; Riley, A. P.; Garcia, A.; Shirai, T.; Svec, R. L.; Hergenrother, P. J.